KINSHASA, Democratic Republic of the Congo and MIAMI, Sept. 12, 2025 /PRNewswire/ -- The Minister of Health from the Democratic Republic of the Congo (DRC) has declared an outbreak of Ebola virus disease (EVD) in Kasai Province after samples tested at the National Institute of Biomedical Research (INRB) in Kinshasa confirmed the cause of the EVD outbreak as Orthoebolavirus zairense (EBOV) (formerly, Zaire ebolavirus). Infection cause by Orthoebolavirus zairense, referred to as Ebola virus diseas

Ryan has been a driving force in Directorie’s growth” — Erika Sinner CHESTERFIELD, MO, UNITED STATES, September 12, 2025 / EINPresswire.com / -- Directorie , a fast-growing strategic commercialization partner for the pharmaceutical, biotech, and med device industries, today announced the promotion of Ryan Rausch to President, effective immediately. A founding member of the Directorie team, Rausch has been instrumental in shaping the company’s operational framework, building its Chief of Staff di

This recall involves correcting certain devices through a software update and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction. Affected Product Product Names: Dexcom G7 Continuous Glucose Monitoring (CGM) Android App Dexcom G7 CGM iOS App Dexcom G7 CGM watchOS App Dexcom ONE+ CGM Android App Dexcom ONE+ CGM iOS App The affected A

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program . This recall involves correcting certain devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction. Affected Product The FDA is aware that Boston Scientific has issued a letter notifying affected customers that certain ENDOTAK R

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product Product Description Model Number UDI-DI DreamStation Auto CPAP UDSX500S11F 00606959423314 DreamStation Auto BiPAP UDSX700S11F 00606959423338 DreamStation Auto CPAP UFRX500S14 00606959455045 What to Do On June 6, 2025, Philips Respironics sent all affected customers an

BIRMINGHAM, Ala. and BOSTON and DALLAS, Sept. 12, 2025 /PRNewswire/ -- Resbiotic Nutrition, Inc., a physician-scientist founded health and wellness company, today announced it has raised a total of $14.5 million, including a recently concluded $8 million Series A round supported by major shareholders Sororibus Capital and Biostack Ventures. The new funding will be used to expand the company's product portfolio, scale retail and ecommerce distribution, and strengthen its B2B ingredient and for

CDER Researchers have been investigating how pharmacokinetic (PK) modeling can support a determination of bioequivalence (BE) for topical drug products. In the case of a generic diclofenac sodium topical gel, 1%, CDER found that physiologically based pharmacokinetic (PBPK) modeling supported an alternative BE approach that does not include a comparative clinical endpoint BE study. The abbreviated new drug application (ANDA) that was approved using this approach is a significant milestone for the

WASHINGTON, DC, UNITED STATES, September 12, 2025 / EINPresswire.com / -- NMAC (formerly the National Minority AIDS Council) today condemned the House Labor–Health and Human Services (LHHS) appropriations bill, which proposes over $2 billion in cuts to critical HIV programs—undermining President Trump’s FY 2026 priority of ending the HIV epidemic. The bill eliminates all CDC HIV prevention funding, guts the bipartisan Ending the HIV Epidemic (EHE) initiative originally launched under President T

The National Hip Fracture Database’s 2025 report ‘Room for improvement: hip fracture care in 2024’ highlights key ways in which clinicians, managers, and policymakers can improve care and outcomes for frail and older patients. Each year over 70,000 people in England, Wales and Northern Ireland have a hip fracture and a quarter of them can expect to have another fragility fracture in the future. Unless something is done to prevent such fractures, it is estimated that the total of number of hip fr

$4.7 million upfront with up to an additional approximately $8.3 million of potential aggregate gross proceeds upon the exercise in full of warrants BOTHELL, Wash., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc., (Nasdaq: COCP) (the “Company” or “Cocrystal”), today announced that it has entered into definitive agreements for the purchase and sale of 2,764,710 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.70 per share in a registe